Recombinant multi-species Cystatin B/CSTB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cystatin B/CSTB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]
The Alternative Names of target: CPI-B,CST6,CSTB,Cstb,Cyb,Cystatin B,Cystatin-B,EPM1,EPM1A,Epm1,Liver thiol proteinase inhibitor,PME,STFB,Stefin-B,Stfb,ULD,cystatin-B
Go
to Cystatin B/CSTB products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP5778-Ag-1/ GM-Tg-hg-IP5778-Ag-2 | Human Cystatin B/CSTB protein | Human |
| GM-Tg-rg-IP5778-Ag-1/ GM-Tg-rg-IP5778-Ag-2 | Rat Cystatin B/CSTB protein | Rat |
| GM-Tg-mg-IP5778-Ag-1/ GM-Tg-mg-IP5778-Ag-2 | Mouse Cystatin B/CSTB protein | Mouse |
| GM-Tg-cynog-IP5778-Ag-1/ GM-Tg-cynog-IP5778-Ag-2 | Cynomolgus/Rhesus macaque Cystatin B/CSTB protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP5778-Ag-1/ GM-Tg-felg-IP5778-Ag-2 | Feline Cystatin B/CSTB protein | Feline |
| GM-Tg-cang-IP5778-Ag-1/ GM-Tg-cang-IP5778-Ag-2 | Canine Cystatin B/CSTB protein | Canine |
| GM-Tg-bovg-IP5778-Ag-1/ GM-Tg-bovg-IP5778-Ag-2 | Bovine Cystatin B/CSTB protein | Bovine |
| GM-Tg-equg-IP5778-Ag-1/ GM-Tg-equg-IP5778-Ag-2 | Equine Cystatin B/CSTB protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP5778-Ag-1/ GM-Tg-hg-IP5778-Ag-2;
GM-Tg-rg-IP5778-Ag-1/ GM-Tg-rg-IP5778-Ag-2;
GM-Tg-mg-IP5778-Ag-1/ GM-Tg-mg-IP5778-Ag-2; GM-Tg-cynog-IP5778-Ag-1/ GM-Tg-cynog-IP5778-Ag-2; GM-Tg-felg-IP5778-Ag-1/ GM-Tg-felg-IP5778-Ag-2; GM-Tg-cang-IP5778-Ag-1/ GM-Tg-cang-IP5778-Ag-2; GM-Tg-bovg-IP5778-Ag-1/ GM-Tg-bovg-IP5778-Ag-2; GM-Tg-equg-IP5778-Ag-1/ GM-Tg-equg-IP5778-Ag-2 |
| Products Name | Cystatin B/CSTB protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Cystatin B/CSTB |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cystatin B/CSTB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.